Risk Assessment of Prostatic Pathology in Patients Undergoing Radical Cystoprostatectomy

European Urology

Volumn 53, Issue 2, 2008, Pages 370-375

  Pettus, Joseph A ^a   Al Ahmadie, Hikmat ^a   Barocas, Daniel A ^a   Koppie, Theresa M ^a   Herr, Harry ^a   Donat, S Machele ^a   Dalbagni, Guido ^a   Reuter, Victor E ^a   Olgac, Semra ^a   Bochner, Bernard H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder cancer; Prostate cancer; Prostate sparing cystectomy; Radical cystoprostatectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; BLADDER NECK; CANCER LOCALIZATION; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CYSTECTOMY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS;

EID: 37349063149     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.07.031     Document Type: Article

References (24)

1. Kessler T.M., Burkhard F.C., Perimenis P., et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 172 (2004) 1323-1327
2. Schoenberg M.P., Walsh P.C., Breazeale D.R., Marshall F.F., Mostwin J.L., and Brendler C.B. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 155 (1996) 490-494
3. Herr H.W., Bochner B.H., Dalbagni G., Donat S.M., Reuter V.E., and Bajorin D.F. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
4. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
5. Vallancien G., Abou El Fettouh H., Cathelineau X., Baumert H., Fromont G., and Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 168 (2002) 2413-2417
6. Muto G., Bardari F., D'Urso L., and Giona C. Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results. J Urol 172 (2004) 76-80
7. Botto H., Sebe P., Molinie V., Herve J.M., Yonneau L., and Lebret T. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int 94 (2004) 1021-1025
8. Colombo R., Bertini R., Salonia A., et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 171 (2004) 1819-1822
9. Revelo M.P., Cookson M.S., Chang S.S., Shook M.F., Smith Jr. J.A., and Shappell S.B. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171 (2004) 646-651
10. Ruffion A., Manel A., Massoud W., et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65 (2005) 703-707
11. Reese J.H., Freiha F.S., Gelb A.B., Lum B.L., and Torti F.M. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol 147 (1992) 92-95
12. Donat S.M., Genega E.M., Herr H.W., and Reuter V.E. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 165 (2001) 1117-1120
13. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368-374
14. Hautmann R.E., and Stein J.P. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am 32 (2005) 177-185
15. Kouriefs C., Fazili T., Masood S., Naseem M.S., and Mufti G.R. Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int 75 (2005) 213-216
16. Kefer J.C., Voelzke B.B., Flanigan R.C., Wojcik E.M., Waters W.B., and Campbell S.C. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology 66 (2005) 1251-1255
17. Nixon R.G., Chang S.S., Lafleur B.J., Smith J.J., and Cookson M.S. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 167 (2002) 502-505
18. Donat S.M., Wei D.C., McGuire M.S., and Herr H.W. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 165 (2001) 1580-1584
19. Karakiewicz P.I., Shariat S.F., Palapattu G.S., et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 50 (2006) 1254-1262
20. Nieuwenhuijzen J.A., Meinhardt W., and Horenblas S. Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol 173 (2005) 1314-1317
21. Montironi R., Mazzucchelli R., Santinelli A., Scarpelli M., Beltran A.L., and Bostwick D.G. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 36 (2005) 646-654
22. Bott S.R., Young M.P., Kellett M.J., and Parkinson M.C. Anterior prostate cancer: is it more difficult to diagnose?. BJU Int 89 (2002) 886-889
23. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 (2006) 529-534
24. Fahmy N.M., Mahmud S., and Aprikian A.G. Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature. Eur Urol 50 (2006) 1176-1182